This inventor holds 1 USPTO granted patent. Top assignee: Viiv Healthcare UK (No. 4) Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Neil A. Strotman: Innovator in HIV Research
Introduction
Neil A. Strotman is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of HIV research, particularly through his innovative methods for producing HIV maturation inhibitors. His work is crucial in the ongoing battle against HIV/AIDS.
Latest Patents
Strotman holds a patent for "Methods of producing an HIV maturation inhibitor." This patent outlines a method for producing an HIV maturation inhibitor compound using betulin as the starting material, employing Lossen rearrangement techniques. This innovative approach has the potential to advance therapeutic options for HIV treatment.
Career Highlights
Neil A. Strotman is associated with ViiV Healthcare UK (No. 4) Limited, a company dedicated to the development of innovative medicines for the treatment of HIV. His role in this organization underscores his commitment to improving health outcomes for individuals affected by HIV.
Collaborations
Strotman has collaborated with talented professionals in his field, including Adrian Ortiz and Maxime Soumeillant. These partnerships enhance the research and development efforts within the company and contribute to the advancement of HIV treatment options.
Conclusion
Neil A. Strotman's work exemplifies the impact of innovation in the medical field, particularly in the fight against HIV. His contributions through patents and collaborations highlight the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile